Three Months ended

March 31,

2015

2014

Cash paid for interest

$

12,557

$

39,116

Series C Dividend payable in accrued expenses

$

--

$

17,574

Series D Dividend payable in accrued expenses

$

15,819

$

45,665

Non-Cash investing and financing transactions

Shares issued for consulting services

$

25,500

$

--

Beneficial conversion feature on warrants issued in

conjunction with Series D preferred shares

$

--

$

13,347

Shares issued in acquisition of Dr. Pave

$

--

$

175,000